BUSINESS DEVELOPMENT FB Twitter LinkedIn

BUSINESS DEVELOPMENT

We research and develop breakthrough technologies and products that improve vision, and then, we invest any revenues from this work in our eye care programs around the world.

BUSINESS DEVELOPMENT STRATEGY

We are flexible in how we conduct research and collaborate with partners to create new, and improve existing, commercial products. This includes the following approaches:
Co-development
Working with an industry partner to achieve commercially viable products and solutions.

We have co-developed several market leading contact lens products including the first silicone hydrogel contact lens to be approved for 30-night extended wear with Ciba Vision (now Alcon). Find out more about our co-development efforts.
Licensing
Translation of our research into commercially viable products and solutions through licensing of our patented technology to industry partners.

In conjunction with the Vision CRC program, we have licensed intraoperative autorefraction and intraoperative optical coherence tomography technologies to industry partner Bioptigen (now Leica Microsystems) for application in ophthalmic surgical procedures.
Strategic partnerships
Working with global experts to expedite development of commercially viable products and solutions.

We collaborate with leading research organisations and individuals to advance our knowledge about, and develop treatments for, the most common eye conditions – myopia, presbyopia, hyperopia and astigmatism – and to improve contact lens comfort.

Commercial returns from partnerships are distributed on a project equity basis calculated on the effort and involvement of collaborators. This includes partnerships which may be driven by Brien Holden Vision Institute but result in larger commercial returns going to other project partners.

“I have had the opportunity to work with some really great individuals….talented and dedicated scientists, who are not only advancing our understanding of vision…but also working to provide excellence in eye care for everyone.

Brien Holden Vision Institute has an equitable policy of sharing royalties generated through translational research collaborations. The University of Houston has benefitted from that in the projects we have worked on.”
(Dr Earl Smith lll, Dean of University of Houston College of Optometry)
Fee-for-service
Produce a prescribed deliverable based on the client’s requirements.

We provide services in the areas of clinical research, technology/engineering (including metrology), education and public health.

We have conducted a large number of clinical studies to evaluate existing or prototype products for commercial partners. Find out more about our research capabilities.
Grants
Seek external funding opportunities, particularly for collaborative research projects.

We have been the lead partner in four Cooperative Research Centres (CRCs), a program established by the Australian Government to bring researchers and industry together on the development of breakthrough products.

The CRCs were:
  • Cooperative Research Centre for Eye Research and Technology (CRCERT) - 1991 to 1997
  • CRCERT 2 - 1997 to 2003
  • Vision Cooperative Research Centre (Vision CRC) - 2003 to 2010
  • Vision CRC 2 - 2010 to 2015
These CRCs produced eye care products which have so far generated over $300 million in royalties for partner organisations.
Contact Lens

INTELLECTUAL PROPERTY (IP) MANAGEMENT

IP Management
Our IP portfolio (patents, trademarks and domain names) is managed by an in-house team (IP Counsel, IP Manager and an IP coordinator). The team actively oversee and manage the prosecution, registration and maintenance of the IP portfolio in consultation with external IP and trademark attorneys and registries.

They provide the following services: managing patent records and prior article searches, drafting specifications, infringement and validity opinions, recommendations on filing and prosecution of patents and freedom to operate (FTO) analysis.

In addition, the IP team also supports the needs, as required, by our stakeholders, involving inventors, project and legal teams, board, senior management, collaborators and industry partners.

OUR AREAS OF EXPERTISE

Our multidisciplinary research, education and public health team includes experts in epidemiology, clinical research, biological sciences, technology development and optometry, ophthalmology and opticianry.

Areas that we specialise in include:
  • Myopia
  • Presbyopia
  • Contact lens - design and performance
  • Contact lens - infection and inflammation
  • Ocular microbiology
  • Epidemiology
  • Refractive error
  • Children’s vision
  • Optics of the eye
  • Contact lens care solutions
  • Biostatistics
  • Public health

COLLABORATION

We have more than 40 years of experience in collaborating with leading industry and research organisations on the development of superior vision care products and advancement of knowledge about ocular health.

This includes 25 years as part of the Australian Government’s Cooperative Research Centres Programme and working with major manufacturers on the development of contact lens, contact lens solution and spectacle lens products.

Our collaboration model is based around a fair distribution of project equity for each partner, providing returns on product success based on the monetary value each party contributes to the project.
Collaborators

"I have had the opportunity to work with some really great individuals….talented and dedicated scientists, who are not only advancing our understanding of vision…but also working to provide excellence in eye care for everyone.

Brien Holden Vision Institute has an equitable policy of sharing royalties generated through translational research collaborations. The University of Houston has benefitted from that in the projects we have worked on."

Dr Earl Smith III, Dean of University of Houston College of Optometry